Translating hemoglobin A1c into average blood glucose: Implications for clinical chemistry

Clinical Chemistry

Volumn 54, Issue 11, 2008, Pages 1756-1758

  Sacks, David B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

BLOOD GLUCOSE MONITORING; CLINICAL CHEMISTRY; CLINICAL EFFECTIVENESS; CLINICAL LABORATORY; DIABETES CONTROL; DIABETES MELLITUS; ERYTHROCYTE LIFESPAN; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; HEALTH CARE PERSONNEL; HUMAN; LONG TERM EXPOSURE; MEASUREMENT; MEASUREMENT ERROR; METABOLIC REGULATION; MICROANGIOPATHY; OUTCOME ASSESSMENT; PATIENT CARE; SELF MONITORING; SHORT SURVEY; ARTICLE; BLOOD; METHODOLOGY; MONITORING;

BLOOD GLUCOSE; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MONITORING, PHYSIOLOGIC;

EID: 55349142109     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2008.113282     Document Type: Short Survey

References (5)

1. ADAG Study Group. Translating the hemoglobin A1c assay into estimated average glucose values. Diabetes Care 2008;31:1473-8.
2. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
3. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. U.K. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
5. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-8.